KIMBERLY THOMPSON: Open Payments
NPI 1144892407 · ROCHESTER, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,948 in 22 payments from 6 companies in 2025. Trend: 2023 $18,699 · 2024 $32,238 · 2025 $6,948
Consulting: $3,060Travel & lodging: $1,892Speaker / faculty: $1,230Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 8 | $3,544 |
| Merck Sharp & Dohme LLC | 10 | $3,215 |
| Kerecis Limited | 1 | $92 |
| CVRx, Inc. | 1 | $54 |
| United Therapeutics Corporation | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $16 |
Products named: UPTRAVI, OPSYNVI, WINREVAIR, Kerecis SurgiClose, Barostim Neo System, FUROSCIX, VERQUVO.
Industry payments across MN — which companies pay providers there.
